“…As such, reported treatments include aggressive systemic agents geared toward controlling the IGD-associated systemic disease, which may also clear the IGD (systemic steroids, 38 etanercept, 38,47 methotrexate, 36,38 cyclosporine, 46 intravenous immunoglobulin, 71 tocilizumab, 72 and ustekinumab 50 ). There are reports of improvement with topical steroids, 38,42,46 nonsteroidal antiinflammatory drugs, 46,73 systemic corticosteroids, 43,46 dapsone, and hydroxychloroquine. 46 Infliximab was used for a recalcitrant case.…”